{ "items": [ "\n\n
\n \n 11 October 2022\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n \n \n Funding\n \n \n\n \n\n\n
\n \n\n \n \n \nThe Leducq Foundation has awarded $7.5 million to researchers at the University of Oxford and their collaborators to advance immunotherapy as a treatment for cardiovascular disease, the leading cause of death in the UK.
\n \n\n\n \n 8 September 2022\n \n
\n\n \n\n \n\n \n \n \n \n Funding\n \n \n\n \n\n\n
\n \n\n \n \n \nTwo new projects led by Tal Arnon and Irina Udalova have been awarded Medical Research Council (MRC) funding.
\n \n\n\n \n 22 July 2022\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n\n \n\n\n
\n \n\n \n \n \nSince 2013 the Kennedy Institute of Rheumatology has been running a Career Development Programme, a scheme to help early career researchers launch their own independent laboratories, and more recently the Innovator Investigator Programme to bring new technologies to core research themes.
\n \n\n\n \n 12 July 2022\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n\n \n\n\n
\n \n\n \n \n \nThe Kennedy Trust has announced Dr Stephen Simpson as its new Chief Executive Officer from 1 July 2022.
\n \n\n\n \n 5 July 2022\n \n
\n\n \n\n \n\n \n \n \n \n Funding\n \n \n \n \n General\n \n \n\n \n\n\n
\n \n\n \n \n \nA new \u00a31.5M grant from the Medical Research Council (MRC) to the Powrie Group at the Kennedy Institute will help define different pathotypes of inflammatory bowel diseases that could lead to better and more focused treatments for patients.
\n \n\n\n \n 30 June 2022\n \n
\n\n \n\n \n\n \n \n \n \n Awards\n \n \n \n \n General\n \n \n\n \n\n\n
\n \n\n \n \n \nYoshi Itoh, Associate Professor and Principal Investigator Cell Migration Group at the Kennedy Institute has been awarded the International Dupuytren Award 2022.
\n \n\n\n \n 22 June 2022\n \n
\n\n \n\n \n\n \n \n \n \n Awards\n \n \n\n \n\n\n
\n \n\n \n \n \nThe University of Oxford has awarded the title of Associate Professor to Adam Cribbs and Luke Jostins.
\n \n\n\n \n 6 June 2022\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n\n \n\n\n
\n \n\n \n \n \nProfessor Fiona Powrie was honoured in the 2022 Queen\u2019s Birthday Honours List, published as Her Majesty celebrates her Platinum Jubilee.
\n \n\n\n \n 26 May 2022\n \n
\n\n \n \n \n\n \n \n \nThe whole of the Kennedy Institute decamped to St Catherine\u2019s college in Oxford on 23/24 May to share and celebrate the Institute\u2019s science, and to strengthen ties across individual research groups. It was great to have everyone back together face to face and the event was buzzing with excitement.
\n \n\n\n \n 30 April 2022\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n\n \n\n\n
\n \n\n \n \n \nInjection of the anti-TNF drug adalimumab into Dupuytren\u2019s disease nodules is effective in reducing nodule hardness and nodule size.
\n \n\n\n \n 19 April 2022\n \n
\n\n \n \n \n\n \n \n \nThe Kennedy Institute has been announced as one of 7 new research clusters by the MRC National Mouse Genetics Network
\n \n\n\n \n 12 April 2022\n \n
\n\n \n\n \n\n \n \n \n \n Funding\n \n \n \n \n General\n \n \n\n \n\n\n
\n \n\n \n \n \nCongratulations to Professor Arnon on her successful Wellcome Trust Investigator Award entitled: \u201cSpatiotemporal basis of adaptive immunity in the spleen.\u201d
\n \n\n\n \n 1 April 2022\n \n
\n\n \n \n \n\n \n \n \nBy studying blood vessels at single cell resolution, Professor Jagdeep Nanchahal and colleagues found that in Dupuytren\u2019s disease, a fibrotic disorder of the hand, the vasculature is key to orchestrating the development of human fibrosis.
\n \n\n\n \n 31 March 2022\n \n
\n\n \n \n \n\n \n \n \nResearchers at the Kennedy Institute of Rheumatology have used 3D and live-imaging to show how resident memory B cells boost antibodies to fight influenza.
\n \n\n\n \n 23 March 2022\n \n
\n\n \n \n \n\n \n \n \nThe COVID-19 Multi-omic Blood Atlas (COMBAT) has identified blood hallmarks of COVID-19 involving particular immune cell populations and their development, components of innate and adaptive immunity, and connectivity with the inflammatory response.
\n \n\n\n \n 15 March 2022\n \n
\n\n \n\n \n\n \n \n \n \n Funding\n \n \n\n \n\n\n
\n \n\n \n \n \nProfessors Matthew Higgins and Michael Dustin from the University of Oxford, Prof Gavin Wright from the University of York, and Professors Shiroh Iwanaga and Hisashi Arase from Osaka University have secured a Wellcome Collaborative Award for their study \u201cHow do RIFINs and STEVORs modulate human immunity during malaria?\u201d
\n \n\n\n \n 7 March 2022\n \n
\n\n \n\n \n\n \n \n \n \n Funding\n \n \n\n \n\n\n
\n \n\n \n \n \nThe \u00a33.9M Wellcome Collaborative Award will be used to identify the drivers of pain in people living with rheumatoid arthritis.
\n \n\n\n \n 12 January 2022\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n\n \n\n\n
\n \n\n \n \n \nMoving to the University of Oxford with the Arthritis Therapy Acceleration Programme (A-TAP) will help accelerate the discovery of new treatments for inflammatory diseases.
\n \n\n\n \n 11 January 2022\n \n
\n\n \n \n \n\n \n \n \nA new study reveals the existence of a powerful ally in the fight against cardiovascular disease, a protective subset of vascular macrophages expressing the C-type lectin receptor CLEC4A2, a molecule which fosters \"good\" macrophage behaviour within the vessel wall.
\n \n\n\n \n 17 December 2021\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n \n \n General\n \n \n\n \n\n\n
\n \n\n \n \n \nThe Kennedy Institute for Rheumatology and the Institute of Developmental and Regenerative Medicine announce the launch of the Oxford-Zeiss Centre of Excellence, providing state-of-the-art imaging technologies to lead future discoveries in global health and disease.
\n \n\n